Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Onemednet
ONMD · NASDAQ · Services-Commercial Physical & Biological Research
Since the trade −4.3% · S&P 500 −11.3% · to Nov 20
Bought at the 52-week low, RSI 36, 37% under its 200-day average, 39 points behind the S&P 500 over 3 months
A Onemednet director paid $750K out of pocket for Onemednet shares. 1 other person at Onemednet bought some too, in the same month. Shares held went up 7% with this purchase.
Since the trade +9.3% · S&P 500 −11.4% · to Nov 20
Bought at the 52-week low, RSI 31, 45% under its 200-day average, 46 points behind the S&P 500 over 3 months
A Onemednet director paid $250K out of pocket for Onemednet shares. 1 other person at Onemednet bought some too, in the same month. Shares held went up 5% with this purchase.
A Onemednet director paid $750K out of pocket for Onemednet shares. 1 other person at Onemednet bought some too, in the same month. It was the first purchase in 7 months.
57 open-market purchases and 7 open-market sales by insiders of ONMD between Apr 23, 2024 and today, placed against the company's last 2 earnings releases. The latest on file was filed Nov 6, 2026.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Jeffrey Yu, Chief Medical Officer, Oct 9, 2026, about $250K. Bought 28 days before the company's next earnings release on 2026-11-06Form 4
Thomas Kosasa, Director, Oct 7, 2026, about $750K. Bought 30 days before the company's next earnings release on 2026-11-06Form 4
Aaron Green, Chief Executive Officer, Sep 24, 2026, about $11K. Sold 43 days before the company's next earnings release on 2026-11-06Form 4
Aaron Green, Chief Executive Officer, Sep 22, 2026, about $37K. Sold 45 days before the company's next earnings release on 2026-11-06Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
Robert Lawrence Golden, Chief Financial Officer, Sep 21, 2026, about $20K. Sold 46 days before the company's next earnings release on 2026-11-06